1 / 1

Novel Parkin Function as p53 Repressor: Implications for Neurodegenerative Diseases

Join us on December 17, 2013, at 14:00 for a conference by Pr. Frédéric Checler, Director of the Cellular and Molecular Biology of Aging Lab and President of the Scientific Committee of the European League Against Alzheimer's Disease. He will discuss the novel function of Parkin as a transcriptional repressor of p53 and its implications for neurodegenerative diseases and cerebral cancers. This insightful presentation will shed light on new therapeutic avenues and biological mechanisms underpinning these conditions.

daisy
Download Presentation

Novel Parkin Function as p53 Repressor: Implications for Neurodegenerative Diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Conférencier invité du département de Biochimie PrFrédéric Checler • Directeur du laboratoire de Biologie Cellulaire et Moléculaire du vieillissement cérébral normal et pathologique. • Président du comité scientifique de la Ligue Européenne Contre la Maladie d’Alzheimer. Institut de Pharmacologie moléculaire et cellulaireUniversité de Nice, Sophia Antipolis Titre de la conférence: A novel parkin function as p53 transcriptional repressor: implications for neurodegenerative diseases and cerebral cancers Mardi 17 décembre 2013 à 14 h Local Z8 – 1049-1050 (PRAC)

More Related